Previsioni

Non sono disponibili dati degli analisti per questa azienda.

Notizie Vai al feed delle notizie

Silex Microsystems achieves spectacular stock market debut on Nasdaq Stockholm

Silex Microsystems’ share briefly jumped to 210 SEK on its first trading day, about 160% above the issue price of 81 SEK, and later traded at 154.50 SEK (almost +91% versus the issue price). Market capitalization is around 16.5 billion SEK (roughly €1.5 billion). Through the IPO, Silex together with Chinese shareholder Sai MicroElectronics raised about 2 billion SEK (€185 million), funds intended for expansion and the purchase of manufacturing equipment in the U.S. Sai MicroElectronics remains slightly under 10% owned, which is seen as a potential risk for the U.S. expansion. » Altro su finanzen.net
Silexion Therapeutics increases authorized share capital after shareholder approval

Shareholders of Silexion Therapeutics Corp approved an amendment to increase the company’s authorized share capital at a reconvened extraordinary general meeting. The authorized capital was raised from USD 20,000 (1,481,482 common shares) to USD 121,500 (9,000,000 common shares); the amendment was filed with the Cayman Islands registrar, took effect immediately, and the common shares are listed on Nasdaq. » Altro su de.investing.com
Silexion drops sharply after warrant exercise agreement

Shares of Silexion Therapeutics Corp fell 22.4% in premarket trading after the company announced a binding agreement for the immediate exercise of certain warrants at a reduced price. The transaction will generate approximately $1.8 million in gross proceeds for Silexion and includes the issuance of new warrants, which can only be exercised after shareholder approval. The proceeds are intended to be used as working capital for general corporate purposes. » Altro su de.investing.com

Dati finanziari dell'azienda

Nell'ultimo trimestre, Silex Systems Ltd. ha registrato ricavi pari a 5,94 Mio€ e un utile netto di −10,20 Mio€

(EUR)	dic 2025	YoY
Ricavi	+5,94 Mio	-
Utile lordo	+1,64 Mio	-
Utile netto	−10,20 Mio	-
EBITDA	+441,16k	-

Dati fondamentali

Metrica	Valore
Capitalizzazione di mercato	+946,58 Mio€
Numero di azioni	278,44 Mio
Massimo/minimo a 52 settimane	+6,70€ - +2,32€
Dividendi	No
Beta	0,48
Rapporto P/E	−32,96
Rapporto PEG	+0,94
Rapporto P/B	+6,78
Rapporto P/S	+111,74

Profilo aziendale

Silex Systems Limited beschäftigt sich mit der Forschung und Entwicklung, der Vermarktung und der Lizenzierung der SILEX-Laser-Urananreicherungstechnologie in Australien. Das Unternehmen entwickelt außerdem die cREO-Technologie für die Integration verschiedener Verbindungshalbleiter-Bauelemente in Silizium-Wafer-basierte Produktionstechniken. Silex Systems Limited wurde 1987 gegründet und hat seinen Sitz in Sydney, Australien.